HEADER TRANSFERASE 13-AUG-09 3IO7 TITLE 2-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS TITLE 2 OF JAK2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: JAK KINASE DOMAIN(UNP RESIDUE 842-1132); COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBEV1 KEYWDS KINASE, INHIBITOR, JAK2, JANUS KINASE, ATP-BINDING, CHROMOSOMAL KEYWDS 2 REARRANGEMENT, DISEASE MUTATION, MEMBRANE, NUCLEOTIDE-BINDING, KEYWDS 3 PHOSPHOPROTEIN, POLYMORPHISM, PROTO-ONCOGENE, SH2 DOMAIN, KEYWDS 4 TRANSFERASE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR H.J.ZUCCOLA,M.W.LEDEBOER,A.C.PIERCE REVDAT 5 06-NOV-24 3IO7 1 REMARK REVDAT 4 13-MAR-24 3IO7 1 COMPND SOURCE REMARK SEQADV REVDAT 4 2 1 LINK REVDAT 3 01-NOV-17 3IO7 1 REMARK REVDAT 2 17-NOV-09 3IO7 1 JRNL REVDAT 1 10-NOV-09 3IO7 0 JRNL AUTH M.W.LEDEBOER,A.C.PIERCE,J.P.DUFFY,H.GAO,D.MESSERSMITH, JRNL AUTH 2 F.G.SALITURO,S.NANTHAKUMAR,J.COME,H.J.ZUCCOLA,L.SWENSON, JRNL AUTH 3 D.SHLYAKTER,S.MAHAJAN,T.HOOCK,B.FAN,W.J.TSAI,E.KOLACZKOWSKI, JRNL AUTH 4 S.CARRIER,J.K.HOGAN,R.ZESSIS,S.PAZHANISAMY,Y.L.BENNANI JRNL TITL 2-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE JRNL TITL 2 INHIBITORS OF JAK2. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 6529 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19857967 JRNL DOI 10.1016/J.BMCL.2009.10.053 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 3 NUMBER OF REFLECTIONS : 9384 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.600 REMARK 3 FREE R VALUE TEST SET COUNT : 710 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 REFLECTION IN BIN (WORKING SET) : 481 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 71.60 REMARK 3 BIN R VALUE (WORKING SET) : 0.2490 REMARK 3 BIN FREE R VALUE SET COUNT : 41 REMARK 3 BIN FREE R VALUE : 0.3200 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2362 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 36 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.20000 REMARK 3 B22 (A**2) : 2.40000 REMARK 3 B33 (A**2) : -0.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.427 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.281 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.843 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.849 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2444 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3293 ; 1.326 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 281 ; 6.034 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 124 ;40.741 ;24.113 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 459 ;17.663 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;18.781 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 343 ; 0.090 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1857 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1011 ; 0.201 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1619 ; 0.308 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 68 ; 0.150 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 45 ; 0.152 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.146 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1462 ; 0.626 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2292 ; 1.126 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1122 ; 1.306 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1001 ; 2.126 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3IO7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-AUG-09. REMARK 100 THE DEPOSITION ID IS D_1000054655. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NO BUFFER ADDED REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9424 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.31600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.1 - 1.5 D-L MALIC ACID, PH NO BUFFER REMARK 280 ADDED, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.59700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 33.59700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 46.96100 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.87600 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 46.96100 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.87600 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 33.59700 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 46.96100 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 50.87600 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 33.59700 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 46.96100 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 50.87600 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 820 REMARK 465 GLY A 821 REMARK 465 SER A 822 REMARK 465 SER A 823 REMARK 465 HIS A 824 REMARK 465 HIS A 825 REMARK 465 HIS A 826 REMARK 465 HIS A 827 REMARK 465 HIS A 828 REMARK 465 HIS A 829 REMARK 465 SER A 830 REMARK 465 SER A 831 REMARK 465 GLY A 832 REMARK 465 LEU A 833 REMARK 465 VAL A 834 REMARK 465 PRO A 835 REMARK 465 ARG A 836 REMARK 465 GLY A 837 REMARK 465 SER A 838 REMARK 465 HIS A 839 REMARK 465 ASN A 840 REMARK 465 MET A 841 REMARK 465 ASN A 859 REMARK 465 PHE A 860 REMARK 465 ALA A 920 REMARK 465 GLY A 921 REMARK 465 ARG A 922 REMARK 465 ALA A 1131 REMARK 465 GLY A 1132 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 887 99.50 -67.27 REMARK 500 HIS A 944 35.62 -95.39 REMARK 500 LYS A 945 -96.48 -4.24 REMARK 500 ASP A 976 28.59 -156.48 REMARK 500 ALA A 978 143.75 -170.18 REMARK 500 PHE A 995 26.89 -140.76 REMARK 500 TRP A1106 38.97 -90.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1P5 A 1 DBREF 3IO7 A 842 1132 UNP O60674 JAK2_HUMAN 842 1132 SEQADV 3IO7 MET A 820 UNP O60674 EXPRESSION TAG SEQADV 3IO7 GLY A 821 UNP O60674 EXPRESSION TAG SEQADV 3IO7 SER A 822 UNP O60674 EXPRESSION TAG SEQADV 3IO7 SER A 823 UNP O60674 EXPRESSION TAG SEQADV 3IO7 HIS A 824 UNP O60674 EXPRESSION TAG SEQADV 3IO7 HIS A 825 UNP O60674 EXPRESSION TAG SEQADV 3IO7 HIS A 826 UNP O60674 EXPRESSION TAG SEQADV 3IO7 HIS A 827 UNP O60674 EXPRESSION TAG SEQADV 3IO7 HIS A 828 UNP O60674 EXPRESSION TAG SEQADV 3IO7 HIS A 829 UNP O60674 EXPRESSION TAG SEQADV 3IO7 SER A 830 UNP O60674 EXPRESSION TAG SEQADV 3IO7 SER A 831 UNP O60674 EXPRESSION TAG SEQADV 3IO7 GLY A 832 UNP O60674 EXPRESSION TAG SEQADV 3IO7 LEU A 833 UNP O60674 EXPRESSION TAG SEQADV 3IO7 VAL A 834 UNP O60674 EXPRESSION TAG SEQADV 3IO7 PRO A 835 UNP O60674 EXPRESSION TAG SEQADV 3IO7 ARG A 836 UNP O60674 EXPRESSION TAG SEQADV 3IO7 GLY A 837 UNP O60674 EXPRESSION TAG SEQADV 3IO7 SER A 838 UNP O60674 EXPRESSION TAG SEQADV 3IO7 HIS A 839 UNP O60674 EXPRESSION TAG SEQADV 3IO7 ASN A 840 UNP O60674 EXPRESSION TAG SEQADV 3IO7 MET A 841 UNP O60674 EXPRESSION TAG SEQRES 1 A 313 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 313 LEU VAL PRO ARG GLY SER HIS ASN MET THR GLN PHE GLU SEQRES 3 A 313 GLU ARG HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY SEQRES 4 A 313 ASN PHE GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU SEQRES 5 A 313 GLN ASP ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU SEQRES 6 A 313 GLN HIS SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG SEQRES 7 A 313 GLU ILE GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE SEQRES 8 A 313 VAL LYS TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG SEQRES 9 A 313 ASN LEU LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER SEQRES 10 A 313 LEU ARG ASP TYR LEU GLN LYS HIS LYS GLU ARG ILE ASP SEQRES 11 A 313 HIS ILE LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS SEQRES 12 A 313 GLY MET GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG SEQRES 13 A 313 ASP LEU ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN SEQRES 14 A 313 ARG VAL LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU SEQRES 15 A 313 PRO GLN ASP LYS GLU PTR PTR LYS VAL LYS GLU PRO GLY SEQRES 16 A 313 GLU SER PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR SEQRES 17 A 313 GLU SER LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE SEQRES 18 A 313 GLY VAL VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SEQRES 19 A 313 SER LYS SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY SEQRES 20 A 313 ASN ASP LYS GLN GLY GLN MET ILE VAL PHE HIS LEU ILE SEQRES 21 A 313 GLU LEU LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP SEQRES 22 A 313 GLY CYS PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS SEQRES 23 A 313 TRP ASN ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP SEQRES 24 A 313 LEU ALA LEU ARG VAL ASP GLN ILE ARG ASP ASN MET ALA SEQRES 25 A 313 GLY MODRES 3IO7 PTR A 1007 TYR O-PHOSPHOTYROSINE MODRES 3IO7 PTR A 1008 TYR O-PHOSPHOTYROSINE HET PTR A1007 16 HET PTR A1008 16 HET 1P5 A 1 29 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 1P5 (3S)-1-[6-(2-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-3-YL) HETNAM 2 1P5 PYRIMIDIN-4-YL]-N,N-DIETHYLPIPERIDINE-3-CARBOXAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 1P5 C20 H26 N8 O FORMUL 3 HOH *36(H2 O) HELIX 1 1 GLU A 845 ARG A 847 5 3 HELIX 2 2 THR A 888 SER A 904 1 17 HELIX 3 3 SER A 936 HIS A 944 1 9 HELIX 4 4 ASP A 949 THR A 969 1 21 HELIX 5 5 ALA A 978 ARG A 980 5 3 HELIX 6 6 PRO A 1017 TYR A 1021 5 5 HELIX 7 7 ALA A 1022 SER A 1029 1 8 HELIX 8 8 SER A 1032 THR A 1049 1 18 HELIX 9 9 GLU A 1052 LYS A 1055 5 4 HELIX 10 10 SER A 1056 GLY A 1066 1 11 HELIX 11 11 GLY A 1071 ASN A 1084 1 14 HELIX 12 12 PRO A 1095 TRP A 1106 1 12 HELIX 13 13 ASN A 1109 ARG A 1113 5 5 HELIX 14 14 SER A 1115 MET A 1130 1 16 SHEET 1 A 5 LEU A 849 GLY A 856 0 SHEET 2 A 5 SER A 862 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 A 5 GLU A 877 LYS A 883 -1 O LYS A 883 N SER A 862 SHEET 4 A 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 A 5 TYR A 913 CYS A 917 -1 N LYS A 914 O ILE A 928 SHEET 1 B 2 TYR A 972 ILE A 973 0 SHEET 2 B 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 C 2 ILE A 982 ASN A 986 0 SHEET 2 C 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 D 2 PTR A1008 LYS A1009 0 SHEET 2 D 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.33 LINK C PTR A1007 N PTR A1008 1555 1555 1.33 LINK C PTR A1008 N LYS A1009 1555 1555 1.33 SITE 1 AC1 13 LEU A 855 LYS A 857 GLY A 858 VAL A 863 SITE 2 AC1 13 ALA A 880 MET A 929 GLU A 930 TYR A 931 SITE 3 AC1 13 LEU A 932 ARG A 980 ASN A 981 LEU A 983 SITE 4 AC1 13 ASP A 994 CRYST1 93.922 101.752 67.194 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010647 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009828 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014882 0.00000